Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 87


Matrix Assisted Laser Desorption/Ionization Mass Spectrometry Imaging (MALDI MSI) for Monitoring of Drug Response in Primary Cancer Spheroids.

Mittal P, Price ZK, Lokman NA, Ricciardelli C, Oehler MK, Klingler-Hoffmann M, Hoffmann P.

Proteomics. 2019 Aug 31:e1900146. doi: 10.1002/pmic.201900146. [Epub ahead of print] No abstract available.


4-Methylumbelliferone Inhibits Cancer Stem Cell Activation and Overcomes Chemoresistance in Ovarian Cancer.

Lokman NA, Price ZK, Hawkins EK, Macpherson AM, Oehler MK, Ricciardelli C.

Cancers (Basel). 2019 Aug 15;11(8). pii: E1187. doi: 10.3390/cancers11081187.


Protein Paucimannosylation is an Enriched N-glycosylation Signature of Human Cancers.

Chatterjee S, Lee LY, Kawahara R, Abrahams JL, Adamczyk B, Anugraham M, Ashwood C, Sumer-Bayraktar Z, Briggs MT, Chik JHL, Everest-Dass A, Förster S, Hinneburg H, Leite KRM, Loke I, Möginger U, Moh ESX, Nakano M, Recuero S, Sethi MK, Srougi M, Stavenhagen K, Venkatakrishnan V, Wongtrakul-Kish K, Diestel S, Hoffmann P, Karlsson NG, Kolarich D, Molloy MP, Muders MH, Oehler MK, Packer NH, Palmisano G, Thaysen-Andersen M.

Proteomics. 2019 Aug 16:e1900010. doi: 10.1002/pmic.201900010. [Epub ahead of print]


Targeting CDK9 for treatment of colorectal cancer.

Rahaman MH, Lam F, Zhong L, Teo T, Adams J, Yu M, Milne RW, Pepper C, Lokman NA, Ricciardelli C, Oehler MK, Wang S.

Mol Oncol. 2019 Aug 9. doi: 10.1002/1878-0261.12559. [Epub ahead of print]


MALDI Mass Spectrometry Imaging of Early- and Late-Stage Serous Ovarian Cancer Tissue Reveals Stage-Specific N-Glycans.

Briggs MT, Condina MR, Ho YY, Everest-Dass AV, Mittal P, Kaur G, Oehler MK, Packer NH, Hoffmann P.

Proteomics. 2019 Jul 31:e1800482. doi: 10.1002/pmic.201800482. [Epub ahead of print]


Rapid Progression of Low-Grade Cervical Dysplasia into Invasive Cancer during Natalizumab Treatment for Relapsing Remitting Multiple Sclerosis.

Wan KM, Oehler MK.

Case Rep Oncol. 2019 Jan 18;12(1):59-62. doi: 10.1159/000496198. eCollection 2019 Jan-Apr.


Exploring the added value of hospital-registry data for showing local service outcomes: cancers of the ovary, fallopian tube and peritoneum.

Roder D, Davy M, Selva-Nayagam S, Paramasivam S, Adams J, Keefe D, Miller C, Powell K, Fusco K, Buranyi-Trevarton D, Oehler MK.

BMJ Open. 2019 Feb 19;9(2):e024036. doi: 10.1136/bmjopen-2018-024036.


Anti-tumour effects of all-trans retinoid acid on serous ovarian cancer.

Lokman NA, Ho R, Gunasegaran K, Bonner WM, Oehler MK, Ricciardelli C.

J Exp Clin Cancer Res. 2019 Jan 8;38(1):10. doi: 10.1186/s13046-018-1017-7.


Non-Invasive Fluorescent Monitoring of Ovarian Cancer in an Immunocompetent Mouse Model.

Wilson AL, Wilson KL, Bilandzic M, Moffitt LR, Makanji M, Gorrell MD, Oehler MK, Rainczuk A, Stephens AN, Plebanski M.

Cancers (Basel). 2018 Dec 31;11(1). pii: E32. doi: 10.3390/cancers11010032.


S100A10 and Cancer Hallmarks: Structure, Functions, and its Emerging Role in Ovarian Cancer.

Noye TM, Lokman NA, Oehler MK, Ricciardelli C.

Int J Mol Sci. 2018 Dec 19;19(12). pii: E4122. doi: 10.3390/ijms19124122. Review.


Risk and prognostic factors for endometrial carcinoma after diagnosis of breast or Lynch-associated cancers-A population-based analysis.

Johnatty SE, Stewart CJR, Smith D, Buchanan D, Leung Y, Oehler MK, Brand A, Webb PM, Spurdle AB.

Cancer Med. 2018 Dec;7(12):6411-6422. doi: 10.1002/cam4.1890. Epub 2018 Nov 28.


Translating N-Glycan Analytical Applications into Clinical Strategies for Ovarian Cancer.

Briggs MT, Condina MR, Klingler-Hoffmann M, Arentz G, Everest-Dass AV, Kaur G, Oehler MK, Packer NH, Hoffmann P.

Proteomics Clin Appl. 2019 May;13(3):e1800099. doi: 10.1002/prca.201800099. Epub 2018 Nov 9. Review.


The Memorial Sloan Kettering Cancer Center Nomogram is More Accurate than the 2009 FIGO Staging System in the Prediction of Overall Survival in a German Endometrial Cancer Patient Cohort.

Huss A, Ihorst G, Timme-Bronsert S, Hasenburg A, Oehler MK, Klar M.

Ann Surg Oncol. 2018 Dec;25(13):3966-3973. doi: 10.1245/s10434-018-6756-3. Epub 2018 Sep 20.


Using hospital registries in Australia to extend data availability on vulval cancer treatment and survival.

Roder D, Davy M, Selva-Nayagam S, Paramasivam S, Adams J, Keefe D, Olver I, Miller C, Buckley E, Powell K, Fusco K, Buranyi-Trevarton D, Oehler MK.

BMC Cancer. 2018 Aug 30;18(1):858. doi: 10.1186/s12885-018-4759-x.


Novel ex vivo ovarian cancer tissue explant assay for prediction of chemosensitivity and response to novel therapeutics.

Ricciardelli C, Lokman NA, Sabit I, Gunasegaran K, Bonner WM, Pyragius CE, Macpherson AM, Oehler MK.

Cancer Lett. 2018 May 1;421:51-58. doi: 10.1016/j.canlet.2018.02.006. Epub 2018 Feb 6.


Mass Spectrometry Analyses of Multicellular Tumor Spheroids.

Acland M, Mittal P, Lokman NA, Klingler-Hoffmann M, Oehler MK, Hoffmann P.

Proteomics Clin Appl. 2018 May;12(3):e1700124. doi: 10.1002/prca.201700124. Epub 2018 Feb 9. Review.


Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.

Johnatty SE, Tan YY, Buchanan DD, Bowman M, Walters RJ, Obermair A, Quinn MA, Blomfield PB, Brand A, Leung Y, Oehler MK; ANECS Group, Kirk JA, O'Mara TA, Webb PM, Spurdle AB.

Gynecol Oncol. 2017 Nov;147(2):381-387. doi: 10.1016/j.ygyno.2017.08.011. Epub 2017 Aug 17.


CIB2 Negatively Regulates Oncogenic Signaling in Ovarian Cancer via Sphingosine Kinase 1.

Zhu W, Jarman KE, Lokman NA, Neubauer HA, Davies LT, Gliddon BL, Taing H, Moretti PAB, Oehler MK, Pitman MR, Pitson SM.

Cancer Res. 2017 Sep 15;77(18):4823-4834. doi: 10.1158/0008-5472.CAN-17-0025. Epub 2017 Jul 20.


Uterine artery pseudoaneurysm bleeding one decade after caesarean section: A case report.

Johannesson L, Mason J, Oehler MK.

J Obstet Gynaecol Res. 2017 May;43(5):939-942. doi: 10.1111/jog.13301. Epub 2017 Apr 24.


Supplemental Content

Loading ...
Support Center